Financial Statement Components - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Concentration Risk [Line Items] | |||||
| Depreciation and amortization associated with property and equipment | $ 16,700 | $ 12,300 | $ 47,700 | $ 33,900 | |
| Impairment charges of long-lived assets | 1,100 | $ 800 | |||
| Financing arrangement amount | $ 53,900 | ||||
| Financing arrangement term | 5 years | 5 years | |||
| Net present value | $ 48,300 | ||||
| Financing assets, current | $ 9,600 | 9,600 | |||
| Financing assets, noncurrent | 32,400 | 32,400 | |||
| Financing liability, current | 10,779 | 10,779 | $ 0 | ||
| Financing liability, noncurrent | 28,000 | 28,000 | $ 0 | ||
| Securities Action | |||||
| Concentration Risk [Line Items] | |||||
| Litigation settlement amount to be paid by insurers | 11,600 | 11,600 | |||
| Accrued litigation settlement | $ 11,600 | $ 11,600 | |||
| Accounts Receivable | Customer Concentration Risk | One Client | |||||
| Concentration Risk [Line Items] | |||||
| Percentage of total account receivable | 16.00% | ||||
| X | ||||||||||
- Definition Financing Arrangement, Commitment Amount No definition available.
|
| X | ||||||||||
- Definition Financing Arrangement, Net Present Value No definition available.
|
| X | ||||||||||
- Definition Financing Arrangement Term No definition available.
|
| X | ||||||||||
- Definition Financing Assets, Current No definition available.
|
| X | ||||||||||
- Definition Financing Assets, Noncurrent No definition available.
|
| X | ||||||||||
- Definition Financing Liability, Current No definition available.
|
| X | ||||||||||
- Definition Financing Liability, Noncurrent No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|